Cargando…

SARS‐CoV‐2 Omicron variant: Characteristics and prevention

Coronavirus disease 2019 (COVID‐19) has brought about a great threat to global public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant B.1.1.529 has been reported in South Africa and induced a rapid increase in COVID‐19 cases. On November 24, 2021, B.1.1.5...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xuemei, Hong, Weiqi, Pan, Xiangyu, Lu, Guangwen, Wei, Xiawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693031/ https://www.ncbi.nlm.nih.gov/pubmed/34957469 http://dx.doi.org/10.1002/mco2.110

Ejemplares similares

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
por: Ao, Danyi, et al.
Publicado: (2023)

The challenges of COVID‐19 Delta variant: Prevention and vaccine development
por: He, Xuemei, et al.
Publicado: (2021)

Spike protein of SARS‐CoV‐2 Omicron (B.1.1.529) variant has a reduced ability to induce the immune response
por: He, Cai, et al.
Publicado: (2022)

Structural Analysis of the SARS-CoV-2 Omicron Variant Proteins
por: Yang, Qiangzhen, et al.
Publicado: (2021)

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
por: Ao, Danyi, et al.
Publicado: (2022)

Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants
por: Lei, Hong, et al.
Publicado: (2023)

Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants
por: He, Cai, et al.
Publicado: (2023)

Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
por: Xu, Ailan, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant: viral spread dynamics, disease burden, and vaccine effectiveness
por: Sun, Shengzhi, et al.
Publicado: (2022)

Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants
por: Lei, Hong, et al.
Publicado: (2022)

A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2
por: He, Cai, et al.
Publicado: (2023)

Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
por: Xia, Shuai, et al.
Publicado: (2022)

A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus
por: He, Cai, et al.
Publicado: (2021)

Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant
por: Yamasoba, Daichi, et al.
Publicado: (2023)

SARS‐CoV‐2 Omicron variant: A next phase of the COVID‐19 pandemic and a call to arms for system sciences and precision medicine
por: Mostafavi, Ebrahim, et al.
Publicado: (2022)

Characteristic analysis of Omicron‐included SARS‐CoV‐2 variants of concern
por: Yang, Hao, et al.
Publicado: (2022)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2
por: Lei, Hong, et al.
Publicado: (2020)

Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients
por: Deng, Haohui, et al.
Publicado: (2023)

SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
por: Guo, Yifei, et al.
Publicado: (2022)

Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
por: Saito, Akatsuki, et al.
Publicado: (2022)

Importation of SARS-CoV-2 Omicron variant in Beijing, China
por: Li, Fu, et al.
Publicado: (2022)

Improving Nasal Protection for Preventing SARS-CoV-2 Infection
por: Nocini, Riccardo, et al.
Publicado: (2022)

Difference of Clinical Characteristics in Patients with Omicron and Delta Variants of SARS-CoV-2 in Beijing, China
por: Tian, Di, et al.
Publicado: (2023)

Comparison of clinical characteristics between SARS-CoV-2 Omicron variant and Delta variant infections in China
por: Li, Qinggang, et al.
Publicado: (2022)

Omicron variant in the current SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

The mysterious origins of the Omicron variant of SARS-CoV-2
por: Du, Pei, et al.
Publicado: (2022)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

Is the Omicron variant of SARS-CoV-2 coming to an end?
por: Zhao, Yingjie, et al.
Publicado: (2022)

Neutralization and Stability of SARS-CoV-2 Omicron Variant
por: Zeng, Cong, et al.
Publicado: (2021)

Recent insights into SARS‐CoV‐2 omicron variant
por: da Silva, Severino Jefferson Ribeiro, et al.
Publicado: (2022)

Omicron variants of SARS-CoV-2 and long COVID
por: Yang, Chengliang, et al.
Publicado: (2022)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

Ebola virus: a new concern, its virological characteristics, diagnosis, present condition, and treatment during the ongoing SARS-CoV-2 omicron variant – correspondence
por: Uddin, Md. Jamir, et al.
Publicado: (2023)

Risk evaluation and mitigation strategies for newly detected SARS‐CoV‐2 Omicron BF.7 subvariant: A brief report
por: Nazmunnahar,, et al.
Publicado: (2023)

SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics
por: Cao, Qing, et al.
Publicado: (2020)

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
por: Cromer, Deborah, et al.
Publicado: (2021)

Clinical Characteristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea
por: Kim, Min-Kyung, et al.
Publicado: (2022)

Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
por: Zhang, Jianguo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cl5maotkjs25bj9vsipfd0p4jh